Literature DB >> 6819249

Stuporous states or coma induced by the rapid administration of high doses of sodium valproate.

H Gastaut, F Iemolo.   

Abstract

7 cases of stuporous states or coma induced in epileptic subjects by the rapid administration of high doses of sodium valproate are described. Progressive impairment of consciousness began 2 to 7 days after the administration of sodium valproate and induced a slowing of background EEG activity until the delta activity became of high amplitude, generalized, continuous and areactive. The authors believe that the impairment of consciousness in their patients was related to the rapid administration of high doses and a direct intrinsic action of sodium valproate on the brain, as no increase in plasma levels of the drugs in association with valproate was observed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819249     DOI: 10.1007/bf02043308

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  15 in total

1.  Valproate, hyperammonemia, and hyperglycinemia.

Authors:  J A Sills; R H Jones; W H Taylor
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

2.  Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

Authors:  D L Coulter; R J Allen
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

3.  Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.

Authors:  B S Zaret; R R Beckner; A M Marini; W Wagle; C Passarelli
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

4.  [Acute sodium valproate poisoning].

Authors:  R Garnier; E Fournier
Journal:  Nouv Presse Med       Date:  1982-02-27

5.  Hyperammonemia with valproic acid therapy.

Authors:  D L Coulter; R J Allen
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

6.  [Confusional state after addition of a third antiepileptic drug to a phenobarbital-sodium valproate combination].

Authors:  C Marescaux; G Micheletti; L Rumbach; J M Warter
Journal:  Nouv Presse Med       Date:  1981-04-04

7.  Acute intoxication with sodium valproate.

Authors:  D W Chadwick; W J Cumming; I Livingstone; N E Cartlidge
Journal:  Ann Neurol       Date:  1979-12       Impact factor: 10.422

Review 8.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

9.  [Dipropylacetate (sodium valproate) and carbamazepine : a suspicious anticonvulsant combination].

Authors:  F Lhermitte; R Marteau; M Serdaru
Journal:  Nouv Presse Med       Date:  1978-11-25

10.  [Severe vigilance disturbances: a rare complication of sodium valproate treatment (author's transl)].

Authors:  B Cenraud; B Pautrizel; O Berets; P Loiseau
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1980 Oct-Dec
View more
  2 in total

1.  Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid.

Authors:  M Paganini; G Zaccara; F Moroni; R Campostrini; L Bendoni; G Arnetoli; R Zappoli
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  State of stupor from valproic acid during chronic treatment: case report.

Authors:  S Gentile; C Buffa; C Ravetti; I Sacerdote
Journal:  Ital J Neurol Sci       Date:  1991-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.